First Time Loading...

Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 0.75 USD 3.14% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

MNPR Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast MNPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNPR is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

MNPR Lowest Forecast
Wall Street Target
2.02 USD
169% Upside
MNPR Average Forecast
Wall Street Target
2.04 USD
172% Upside
MNPR Highest Forecast
Wall Street Target
2.1 USD
180% Upside
Lowest
Price Target
2.02 USD
169% Upside
Average
Price Target
2.04 USD
172% Upside
Highest
Price Target
2.1 USD
180% Upside
Monopar Therapeutics Inc Competitors:
Price Targets
HOOK
HOOKIPA Pharma Inc
375% Upside
T
6628
Transcenta Holding Limited
347% Upside
HRTX
Heron Therapeutics Inc
164% Upside
4974
Takara Bio Inc
86% Upside
HOOK
HOOKIPA Pharma Inc
375% Upside
T
6628
Transcenta Holding Limited
347% Upside
HRTX
Heron Therapeutics Inc
164% Upside
4974
Takara Bio Inc
86% Upside
IPSC
Century Therapeutics Inc
399% Upside
XBIT
XBiotech Inc
108% Upside
C
CBUS
Cibus Inc
38% Upside
XNCR
Xencor Inc
55% Upside

Revenue
Forecast

Revenue Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Monopar Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
MNPR intrinsic value, competitors valuation, and company profile.
DCF Valuation
MNPR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MNPR stock valuation using valuation multiples.
Wall Street Estimates
MNPR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MNPR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MNPR's stock price target?
Price Target
2.04 USD

According to Wall Street analysts, the average 1-year price target for MNPR is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.